FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885222790> ?p ?o ?g. }

• W2885222790 endingPage "582" @default.
• W2885222790 startingPage "574" @default.
• W2885222790 abstract "Purpose The aim of this study was to localize locoregional lymph node metastases using positron emission tomography with fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) data sets in a large cohort of patients and to evaluate the existing Radiation Therapy Oncology Group (RTOG) clinical target volume (CTV) and the European Society for Radiation Therapy & Oncology (ESTRO) CTV contouring guidelines. Methods and Materials A total of 235 patients with 580 FDG/PET-CT positive locoregional lymph node metastases were included in our analysis. The patients were divided into 4 groups according to their course of disease (primary vs recurrent breast cancer) and the presence or absence of distant metastasis at the time of the FDG-PET/CT staging (distant metastasis vs no distant metastasis). All imaging data were imported into the planning system, and each lymph node was manually contoured. A patient with “standard anatomy” was chosen as a template, and all contoured structures were registered rigidly and nonrigidly to this patient. A comprehensive 3-dimensional atlas was created, including all identified lymph node metastases. The incidences of lymph node metastases were analyzed and are presented with color coding in the atlas. Lymph node levels (axillary, internal mammary, supraclavicular) were contoured according to RTOG and ESTRO guidelines and evaluated. Results The mean volume of the lymph nodes was 1.7 ± 2.6 cm3 with an average diameter of 1.3 ± 0.7 cm. Most lymph nodes were in level I (n = 316; 54.5%) followed by the supraclavicular region (n = 80; 13.8%), level II (n = 57; 9.8%), level III (n = 58; 10.0%), and the internal mammary region (n = 55; 9.5%). The covered lymph node volume was 69.8% ± 35.5% (69.1% ± 36.3%) for primary breast cancer and 57.6% ± 38.9% (51.1% ± 39.1%) for recurrent breast cancer using the RTOG (ESTRO) guidelines. The internal mammary region and supraclavicular region were affected more often in recurrent breast cancer compared with primary breast cancer. The occurrence of lymph node metastases outside the RTOG and ESTRO margins in patients with and without distant metastases was similar. The largest geometric deviations between RTOG/ESTRO CTV contours and lymph node occurrence were measured in the supraclavicular region, the internal mammary region, and level II. Conclusions The provided lymph node atlas illustrates where lymph node metastases occur in different clinical situations and presents areas at high risk (ie “hot spots” of lymph node metastases). The aim of this study was to localize locoregional lymph node metastases using positron emission tomography with fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) data sets in a large cohort of patients and to evaluate the existing Radiation Therapy Oncology Group (RTOG) clinical target volume (CTV) and the European Society for Radiation Therapy & Oncology (ESTRO) CTV contouring guidelines. A total of 235 patients with 580 FDG/PET-CT positive locoregional lymph node metastases were included in our analysis. The patients were divided into 4 groups according to their course of disease (primary vs recurrent breast cancer) and the presence or absence of distant metastasis at the time of the FDG-PET/CT staging (distant metastasis vs no distant metastasis). All imaging data were imported into the planning system, and each lymph node was manually contoured. A patient with “standard anatomy” was chosen as a template, and all contoured structures were registered rigidly and nonrigidly to this patient. A comprehensive 3-dimensional atlas was created, including all identified lymph node metastases. The incidences of lymph node metastases were analyzed and are presented with color coding in the atlas. Lymph node levels (axillary, internal mammary, supraclavicular) were contoured according to RTOG and ESTRO guidelines and evaluated. The mean volume of the lymph nodes was 1.7 ± 2.6 cm3 with an average diameter of 1.3 ± 0.7 cm. Most lymph nodes were in level I (n = 316; 54.5%) followed by the supraclavicular region (n = 80; 13.8%), level II (n = 57; 9.8%), level III (n = 58; 10.0%), and the internal mammary region (n = 55; 9.5%). The covered lymph node volume was 69.8% ± 35.5% (69.1% ± 36.3%) for primary breast cancer and 57.6% ± 38.9% (51.1% ± 39.1%) for recurrent breast cancer using the RTOG (ESTRO) guidelines. The internal mammary region and supraclavicular region were affected more often in recurrent breast cancer compared with primary breast cancer. The occurrence of lymph node metastases outside the RTOG and ESTRO margins in patients with and without distant metastases was similar. The largest geometric deviations between RTOG/ESTRO CTV contours and lymph node occurrence were measured in the supraclavicular region, the internal mammary region, and level II. The provided lymph node atlas illustrates where lymph node metastases occur in different clinical situations and presents areas at high risk (ie “hot spots” of lymph node metastases)." @default.
• W2885222790 created "2018-08-22" @default.
• W2885222790 creator A5018400098 @default.
• W2885222790 creator A5019652919 @default.
• W2885222790 creator A5027036343 @default.
• W2885222790 creator A5044003066 @default.
• W2885222790 creator A5061037633 @default.
• W2885222790 creator A5067838462 @default.
• W2885222790 creator A5080877411 @default.
• W2885222790 creator A5083070882 @default.
• W2885222790 date "2019-03-01" @default.
• W2885222790 modified "2023-09-30" @default.
• W2885222790 title "FDG/PET-CT–Based Lymph Node Atlas in Breast Cancer Patients" @default.
• W2885222790 cites W1770259999 @default.
• W2885222790 cites W1952887255 @default.
• W2885222790 cites W1970483105 @default.
• W2885222790 cites W2040982338 @default.
• W2885222790 cites W2047913201 @default.
• W2885222790 cites W2062616726 @default.
• W2885222790 cites W2088715039 @default.
• W2885222790 cites W2089810107 @default.
• W2885222790 cites W2114349652 @default.
• W2885222790 cites W2119226000 @default.
• W2885222790 cites W2133865595 @default.
• W2885222790 cites W2134467865 @default.
• W2885222790 cites W2136580868 @default.
• W2885222790 cites W2141401917 @default.
• W2885222790 cites W2331430338 @default.
• W2885222790 cites W2467650572 @default.
• W2885222790 cites W2554095516 @default.
• W2885222790 cites W2754855139 @default.
• W2885222790 cites W2758721844 @default.
• W2885222790 cites W4366111328 @default.
• W2885222790 cites W993406450 @default.
• W2885222790 doi "https://doi.org/10.1016/j.ijrobp.2018.07.2025" @default.
• W2885222790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30118822" @default.
• W2885222790 hasPublicationYear "2019" @default.
• W2885222790 type Work @default.
• W2885222790 sameAs 2885222790 @default.
• W2885222790 citedByCount "45" @default.
• W2885222790 countsByYear W28852227902019 @default.
• W2885222790 countsByYear W28852227902020 @default.
• W2885222790 countsByYear W28852227902021 @default.
• W2885222790 countsByYear W28852227902022 @default.
• W2885222790 countsByYear W28852227902023 @default.
• W2885222790 crossrefType "journal-article" @default.
• W2885222790 hasAuthorship W2885222790A5018400098 @default.
• W2885222790 hasAuthorship W2885222790A5019652919 @default.
• W2885222790 hasAuthorship W2885222790A5027036343 @default.
• W2885222790 hasAuthorship W2885222790A5044003066 @default.
• W2885222790 hasAuthorship W2885222790A5061037633 @default.
• W2885222790 hasAuthorship W2885222790A5067838462 @default.
• W2885222790 hasAuthorship W2885222790A5080877411 @default.
• W2885222790 hasAuthorship W2885222790A5083070882 @default.
• W2885222790 hasConcept C121608353 @default.
• W2885222790 hasConcept C126322002 @default.
• W2885222790 hasConcept C126838900 @default.
• W2885222790 hasConcept C127413603 @default.
• W2885222790 hasConcept C142724271 @default.
• W2885222790 hasConcept C199639397 @default.
• W2885222790 hasConcept C2775842073 @default.
• W2885222790 hasConcept C2777649267 @default.
• W2885222790 hasConcept C2779013556 @default.
• W2885222790 hasConcept C2779104521 @default.
• W2885222790 hasConcept C2779223589 @default.
• W2885222790 hasConcept C2779720271 @default.
• W2885222790 hasConcept C2780849966 @default.
• W2885222790 hasConcept C2989005 @default.
• W2885222790 hasConcept C509974204 @default.
• W2885222790 hasConcept C530470458 @default.
• W2885222790 hasConcept C71924100 @default.
• W2885222790 hasConceptScore W2885222790C121608353 @default.
• W2885222790 hasConceptScore W2885222790C126322002 @default.
• W2885222790 hasConceptScore W2885222790C126838900 @default.
• W2885222790 hasConceptScore W2885222790C127413603 @default.
• W2885222790 hasConceptScore W2885222790C142724271 @default.
• W2885222790 hasConceptScore W2885222790C199639397 @default.
• W2885222790 hasConceptScore W2885222790C2775842073 @default.
• W2885222790 hasConceptScore W2885222790C2777649267 @default.
• W2885222790 hasConceptScore W2885222790C2779013556 @default.
• W2885222790 hasConceptScore W2885222790C2779104521 @default.
• W2885222790 hasConceptScore W2885222790C2779223589 @default.
• W2885222790 hasConceptScore W2885222790C2779720271 @default.
• W2885222790 hasConceptScore W2885222790C2780849966 @default.
• W2885222790 hasConceptScore W2885222790C2989005 @default.
• W2885222790 hasConceptScore W2885222790C509974204 @default.
• W2885222790 hasConceptScore W2885222790C530470458 @default.
• W2885222790 hasConceptScore W2885222790C71924100 @default.
• W2885222790 hasIssue "3" @default.
• W2885222790 hasLocation W28852227901 @default.
• W2885222790 hasLocation W28852227902 @default.
• W2885222790 hasOpenAccess W2885222790 @default.
• W2885222790 hasPrimaryLocation W28852227901 @default.
• W2885222790 hasRelatedWork W1563744849 @default.
• W2885222790 hasRelatedWork W161845677 @default.
• W2885222790 hasRelatedWork W1755258021 @default.
• W2885222790 hasRelatedWork W2011286495 @default.
• W2885222790 hasRelatedWork W2057960324 @default.

• next